Kestra Medical Technologies, Ltd. (KMTS) Misses Q1 EPS by 19c, raises guidance

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q1 EPS of ($0.61), $0.19 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $24.6 million, versus $0 reported last year.

GUIDANCE:

Kestra Medical Technologies, Ltd. sees FY2026 revenue of $93 million, versus the consensus of $90.936 million.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance